Salesforce (CRM) Form 4 shows director RSU vesting, 8,612 shares held

Rhea-AI Filing Summary

Salesforce, Inc. (CRM) director Craig Conway reported the vesting of restricted stock units into common stock. On 11/22/2025, 274 restricted stock units were converted to 274 shares of Salesforce common stock at an exercise price of $0, reflecting the terms of the equity award. Following this transaction, Conway beneficially owned 8,612 shares of Salesforce common stock in direct ownership.

The restricted stock units convert to common stock on a one-for-one basis and vest in four equal installments of 25% of the original grant on each of February 22, 2025, May 22, 2025, August 22, 2025, and November 22, 2025. This filing is a routine disclosure of insider equity compensation and its scheduled vesting.

Insider Trade Summary

274 shares exercised/converted

Mixed 2 txns

Insider Conway Craig

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	274	$0.00	--
Exercise	Common Stock	274	$0.00	--

Holdings After Transaction: Restricted Stock Units — 0 shares (Direct); Common Stock — 8,612 shares (Direct)

Footnotes (1)

1. Restricted Stock Units convert to shares of common stock on a one-for-one basis. These restricted stock units vest as to 25% of the original grant on each of February 22, 2025, May 22, 2025, August 22, 2025, and November 22, 2025.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Conway Craig

(Last) (First) (Middle)

415 MISSION STREET

3RD FLOOR

(Street)

SAN FRANCISCO CA 94105

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Salesforce, Inc. [ CRM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/22/2025		M		274	A	$0	8,612	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0(1)	11/22/2025		M			274	02/22/2025(2)	11/22/2025	Common Stock	274	$0	0	D

Explanation of Responses:

1. Restricted Stock Units convert to shares of common stock on a one-for-one basis.

2. These restricted stock units vest as to 25% of the original grant on each of February 22, 2025, May 22, 2025, August 22, 2025, and November 22, 2025.

	/s/ Sarah Dale, Attorney-in-Fact for Craig Conway	11/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Salesforce (CRM) report in this Form 4?

The filing reports that director Craig Conway had 274 restricted stock units convert into 274 shares of Salesforce common stock on 11/22/2025 at an exercise price of $0.

How many Salesforce (CRM) shares does the reporting person own after this transaction?

After the reported transaction, the reporting person beneficially owned 8,612 shares of Salesforce common stock in direct ownership.

What are the vesting terms of the Salesforce (CRM) restricted stock units?

The restricted stock units vest as to 25% of the original grant on each of February 22, 2025, May 22, 2025, August 22, 2025, and November 22, 2025, and each unit converts into one share of common stock.

What is the conversion ratio for Salesforce (CRM) restricted stock units in this filing?

The filing states that the restricted stock units convert to shares of common stock on a one-for-one basis.

Is the reported Salesforce (CRM) Form 4 transaction a purchase or an equity award vesting?

The transaction reflects the vesting and conversion of restricted stock units into common stock at $0 exercise price, rather than an open-market purchase.

What role does the reporting person have at Salesforce (CRM)?

The reporting person is identified as a Director of Salesforce, Inc.